| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.5M | -20.7% |
| R&D Expense | $71.0M | +1.2% |
| SG&A Expense | $26.3M | +2.3% |
| Operating Income | -$80.7M | -17.3% |
| Income Tax | $0 | — |
| Net Income | -$79.5M | -15.6% |
| EPS (Basic) | -$2.76 | -10.8% |
| EPS (Diluted) | -$2.76 | -10.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.7M | -55.6% |
| Accounts Receivable | $3.0M | +0.0% |
| Current Assets | $68.2M | -54.7% |
| Total Assets | $99.9M | -55.8% |
| Current Liabilities | $21.8M | -34.3% |
| Total Liabilities | $42.8M | -58.2% |
| Stockholders' Equity | $57.1M | -53.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$83.5M | -1.7% |
| Capital Expenditures | $522K | -14.8% |
| Investing Cash Flow | -$488K | +20.4% |
| Financing Cash Flow | $4.2M | -92.4% |
| Free Cash Flow | -$84.1M | -1.6% |